ArticleKidney medicine2026
Pandemic-Related Reductions in Respiratory Infections and New-Onset Nephrotic Syndrome: A Multicenter Cohort Study in Japan.
Article in Kidney medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Rationale & Objective: Infectious diseases have been associated with pediatric idiopathic nephrotic syndrome (NS). The effect of pandemic-related changes in infection exposure on NS epidemiology remains unclear. Study Design: Retrospective cohort study. Setting & Participants: Data from children aged 6 months to 15 years from 11 hospitals in Japan, extracted from the Pediatric Medical Information Collection System. Two periods were compared: prepandemic (April 2019-March 2020) and first pandemic year (April 2020-March 2021). Analytical Approach: Event counts (new-onset NS, relapse, respiratory tract infections, acetaminophen prescriptions, coronavirus disease 2019 diagnoses) were modeled using a negative binomial generalized linear mixed model with hospital-specific random intercepts. Sensitivity analyses used zero-inflated Poisson, Poisson mixed models, and quasi-Poisson. Results: There were 218 new-onset NS cases (127 prepandemic, 91 during the pandemic). The pandemic period was associated with a decrease in incidence, and estimates were similar across distributional sensitivity analyses, whereas extended time-window analyses attenuated statistical significance. The relapse rate among 366 patients in remission was 0.094 per person-year before the pandemic and 0.056 per person-year during the pandemic; the period effect was not statistically significant. Respiratory tract infections decreased by approximately half, and acetaminophen prescriptions declined. The number of coronavirus disease 2019 diagnoses increased sharply. Limitations: Observational design limits causal inference. Findings may not generalize beyond Japanese populations. Conclusions: Reduced respiratory infection exposure during the pandemic may be associated with lower new-onset NS incidence. Preventive measures against respiratory infections may help reduce NS occurrence.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.